As of 2026-03-28, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 33.43 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 2376.4%.
The range of the Relative Valuation is 10.49 - 64.64 CAD.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 11.3x | 9.6x |
| Forward P/E multiples | 32.7x - 48.6x | 40.6x |
| Fair Price | 10.49 - 64.64 | 33.43 |
| Upside | 676.7% - 4688.2% | 2376.4% |
| Date | P/E |